Welcome
Support Centre
13 May 2008 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

Submit your study protocol
[ Print-friendly version ]
Ultrasound guided jugular vein cannulation
ISRCTN ISRCTN00203325
ClinicalTrials.gov identifier
Public title Ultrasound guided jugular vein cannulation
Scientific title Internal jugular vein cannulation using ultrasound guidance: a prospective randomised controlled trial
Acronym N/A
Serial number at source N/A
Study hypothesis Real time ultrasound guided cannulation of the internal jugular vein (IJV) is more efficient than catheterisation using ultrasound located landmarks.
Ethics approval Ethics approval received from "Attikon" Hospital Ethics Committee on the 23rd January 2004 (ref: AP. 420/CP "ATTIKON" Hospital).
Study design Prospective randomised controlled trial
Countries of recruitment Greece
Disease/condition/study domain Jugular vein cannulation
Participants - inclusion criteria 1. Patients of the "Attikon" Hospital, in General Surgery, Oncology and Haematology Departments
2. Males and females, from 18 - 80 years of age
Participants - exclusion criteria Patients with internal jugular vein thrombosis.
Anticipated start date 01/02/2004
Anticipated end date 30/05/2008
Status of trial Ongoing
Patient information material
Target number of participants 212 - 556
Interventions Patients who need an internal jugular vein catheter are randomised, using sealed envelopes, in two groups:
Group A (real time ultrasound [U/S]): IJV Cannulation using real time ultrasound
Group B (U/S located landmarks): IJV cannulation using ultrasound located landmarks

Patients with IJV thrombosis were excluded. The success rate of cannulation was measured (attempts less than or equal to three by the same operator), along with the duration of time until successful cannulation and complications.
Primary outcome measure(s) Success rate of cannulation, attempts less than or equal to three by the same operator.
Secondary outcome measure(s) 1. Number of tries
2. Time to complete cannulation
3. Immediate complications (assessed by the operator and his assistance)
4. Place of the catheter using x-ray just after cannulation (assessed by a radiologist)
5. Early complications, measured at days 1, 2 and 5 post cannulation (assesed by a senior surgeon)
6. Later complications (late infections and obstruction of catheters’ "life" up to six months, assesed by a physician and/or a senior nurse)
Sources of funding "Attikon" Teaching Hospital (Greece) - University of Athens
Trial website
Publications
Contact name Prof  Theodore  Liakakos
  Address "Attikon" Hospital
3rd Academic Department of Surgery
Haidari
  City/town Athens
  Zip/Postcode 124 10
  Country Greece
  Email theodlia@otenet.gr
Sponsor "Attikon" Teaching Hospital (Greece) - University of Athens
  Address 1 Rimini Str
Haidari
  City/town Athens
  Zip/Postcode 124 10
  Country Greece
  Email gchklin@med.uoa.gr
Date applied 19/03/2008
Last edited 08/04/2008
Date ISRCTN assigned 08/04/2008
News
28 Sept 2007: 2007 Update of NHS Trusts Clinical Trials Register now available online
Aug 2007: Searches on ISRCTN register can now be bookmarked
Jul 2007: Patient information material field added to the ISRCTN Register
May 2007: WHO launches the International Clinical Trials Registry Search Portal
3 Apr 2007: Q&As regarding trial registration in the UK
4 Dec 2006: Trials taking place in the UK collated in 'Gateway'

© ISRCTN


BioMed Central